China’s robotic surgical systems market to reach $250m by 2033

The country accounted for approximately 30% of APAC’s market share in 2023.

China’s robotic surgical systems market is projected to reach $250m by 2033 amidst rapid healthcare technology and growing demand for minimally invasive procedures, said GlobalData.

The report revealed that in 2023, the country accounted for approximately 30% of the market share in the Asia Pacific (APAC) region.

Moreover, recent developments underscore the impact of these systems on medical practice, such as Shanghai Chest Hospital’s use of Meihua’s NT-2000 system to perform 5G remote robot-assisted lobectomy.

According to Aditi Dakshesh Parikh, medical devices analyst at GlobalData, this adoption potentially advances medical care by enhancing precision, reducing recovery times, and improving patient outcomes.

“This advancement signals a future where China could lead in delivering high-quality, accessible healthcare, driven by cutting-edge technology and reduced reliance on external sources,” Parikh said.